Windtree Therapeutics Secures $520 Million to Build BNB Reserve via Kraken Partnership

Windtree Therapeutics, a biopharmaceutical company, has announced ambitious plans to raise up to $520 million, with the majority of funds targeted at acquiring BNB, the fifth-largest cryptocurrency by market capitalization. The funding includes a $500 million equity line of credit and a separate $20 million stock purchase agreement, contingent upon shareholder approval to increase authorized shares. This strategic initiative follows Windtree's recent collaboration with Kraken, a prominent cryptocurrency exchange, signaling a bold move into the digital asset space. The announcement highlights the growing intersection between traditional biopharma and the cryptocurrency sector, as Windtree seeks to capitalize on the potential of BNB. The move underscores the increasing institutional interest in cryptocurrencies, particularly those with strong utility like BNB. As of July 2025, this development could further solidify BNB's position in the market and attract more institutional investors to the crypto ecosystem.

Windtree Therapeutics Aims for $520 Million Funding to Build BNB Reserve

Windtree Therapeutics has unveiled plans to raise up to $520 million, with nearly all funds earmarked for acquiring BNB, the fifth-largest cryptocurrency by market cap. The biopharma firm secured a $500 million equity line of credit and a separate $20 million stock purchase agreement, pending shareholder approval to increase authorized shares.

The strategic move follows Windtree's recent partnership with Kraken, which will custody the planned BNB treasury. CEO Jed Latkin emphasized the importance of cryptocurrency diversification, calling the funding initiative "essential to our strategy" during a period of institutional crypto adoption.

Viral AI Asset Manager Unilabs Raises $6.1M Amid Solana's Price Volatility

Solana's price rebounds to $185 after a brief correction from $200, while Unilabs—dubbed the 'Solana Slayer'—gains traction with its AI-driven asset management platform. The project has raised $6.1 million by leveraging automated tools and portfolio rewards, contrasting with Solana's reliance on market momentum.

Solana faces resistance between $195 and $255 despite bullish signals, including whale withdrawals of 164,000 SOL from Kraken. Unilabs sidesteps price speculation entirely, using AI to analyze token utility and team strength for portfolio construction.